Images List Premium Download Classic

Prophylactic

Prophylactic-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Compounds and compositions for intracellular delivery of therapeutic agents
Modernatx, Inc.
August 17, 2017 - N°20170233332

The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and peg lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as rna are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, ...
Process for providing protective therapy for biological tissues or fluids
Ojai Retinal Technology, Llc
August 17, 2017 - N°20170232269

A process that provides protective therapy for biological tissues or fluids includes applying a pulsed energy source to a target tissue or a target fluid having a chronic progressive disease or a risk of having a chronic progressive disease to therapeutically or prophylactically treat the target tissue or target fluid. The pulsed energy source has energy parameters selected so as ...
Dendrimer compositions and use in treatment of neurological and cns disorders
Kennedy Krieger Institute, Inc.
August 17, 2017 - N°20170232120

A dendrimer formation, such as a pamam dendrimer or a multiarm peg polymeric formulation has been developed for systemic administration to the brain or central nervous system. In the preferred embodiment, the dendrimers are in the form of dendrimer nanoparticles comprising poly(amidoamine) (pamam) hydroxyl-terminated dendrimers covalently linked to at least one therapeutic, prophylactic or diagnostic agent for treatment of ...
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Therapeutic or prophylactic composition for tdp-43 proteinopathy
Biolectrics Llc
August 10, 2017 - N°20170226508

A prophylactic or therapeutic composition for tdp-43 proteinopathy, comprising: one or more nucleic adds selected from the group consisting of isolated rnas and isolated nucleic acids encoding the rnas, wherein the rnas consist of human mir-33 represented by seq id no: 1, variants of the human mir-33 having one or more mutations, and precursors of the human mir-33 and the variants.
Anti-orai1 antibody
Daiichi Sankyo Company, Limited
August 10, 2017 - N°20170226203

It is intended to provide a therapeutic and/or prophylactic agent for transplant rejections, immunological diseases, allergic diseases, inflammatory diseases, thrombosis, cancers, etc., targeting human orai1. The present invention provides, for example, a pharmaceutical composition comprising an antibody that specifically recognizes human orai1 and has the activity of inhibiting human t cell activation.
Substituted piperidine compound and use thereof
Daiichi Sankyo Company, Limited
August 10, 2017 - N°20170226137

Wherein each symbol is as described in the description, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compounds and compositions for intracellular delivery of therapeutic agents
Modernatx, Inc.
August 10, 2017 - N°20170224844

The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and peg lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as rna are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, ...
Microorganisms inhibiting the formation of axillary malodor
Basf Se
August 10, 2017 - N°20170224747

Described are microorganisms which are able to suppress the production of malodorous compounds by axillary bacteria. Also described are compositions comprising such microorganisms as well as the use of such micoorganisms in cosmetic, prophylactic or therapeutic applications.
Renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor
Euglena Co., Ltd.
August 10, 2017 - N°20170224717

Provided are a novel renal failure progression inhibitor, prophylactic agent for renal failure, and indoxyl sulfate production inhibitor, intended for human use, in particular, for a patient with renal failure. The renal failure progression inhibitor, prophylactic agent for renal failure, and indoxyl sulfate production inhibitor each comprises paramylon derived from euglena or a processed product thereof as an active ingredient. ...
Xanthine oxidase inhibitor
Teijin Pharma Limited
August 03, 2017 - N°20170217948

Provided are a xanthine oxidase inhibitor, a drug for improving vascular endothelial function, and an excellent therapeutic or prophylactic drug for diseases associated with xanthine oxidase such as gout, hyperuricaemia, and for diseases associated with vascular endothelial functional disorder containing a compound represented in a formula (i) or the pharmaceutically acceptable salt thereof as an active ingredient.
Injection needle and device
Chrontech Pharma Ab
August 03, 2017 - N°20170216573

Several needle assemblies and intracellular delivery devices that are used for the delivery of prophylactic and/or therapeutic material (i. E., delivered agents) into a tissue of a subject are disclosed. Preferably, the needle assemblies and/or the intracellular delivery devices comprise needles and/or needle electrodes, which are disposed in an array (e. G., a y-type array having three ...
Flexible and/or elastic brachytherapy seed or strand
Microspherix Llc
August 03, 2017 - N°20170216499

A flexible or elastic brachytherapy strand that includes an imaging marker and/or a therapeutic, diagnostic or prophylactic agent such as a drug in a biocompatible carrier that can be delivered to a subject upon implantation into the subject through the bore of a brachytherapy implantation needle has been developed. Strands can be formed as chains or continuous arrays of ...
Polymer-flavonoid conjugate and uses thereof
Agency For Science, Technology And Research
August 03, 2017 - N°20170216446

There is provided a polymer-flavonoid conjugate, or a pharmaceutically acceptable salt thereof, uses thereof, and methods of making thereof. The disclosed polymer-flavonoid conjugates may be useful in the therapeutic and/or prophylactic treatment of a joint condition in a subject.
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Substituted diketopiperazine analogs for use as drug delivery agents
Mannkind Corporation
August 03, 2017 - N°20170216280

Disclosed are drug delivery systems for the delivery of small molecule and macromolecular drugs. More particularly, disclosed are substituted analogs of 3,6-di(alkyl-4 aminobutyl)-2,5-diketopiperazine (which may also be referred to dkp), their use in the formulation of both small molecule and macromolecular drugs including therapeutic, prophylactic and diagnostic agents, stabilizing agents and systems for their delivery.
Animal models, cell lines and methods for screening hepatitis c virus vaccines
National Research Council Of Canada
August 03, 2017 - N°20170215393

Modified non-human mammalian hepatoma cell lines that express hepatitis c virus (hcv) antigens and which are capable of generating tumours in a syngeneic animal model are provided. The cell lines are generated by genomic integration of an expression construct that comprises one or more hcv antigen-encoding sequences under the control of a constitutive promoter. The expression construct further comprises a ...
Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva
Kyoto University
July 27, 2017 - N°20170211070

The invention provides a prophylactic agent or therapeutic agent for fibrodysplasia ossificans progressiva, containing as an active ingredient a binding inhibitor that inhibits interaction between activin and activin a receptor type i (acvr1), or an expression suppressor that suppresses expression of activin.
Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
Janssen Vaccines & Prevention B.v.
July 27, 2017 - N°20170210787

The disclosure relates to antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau. The disclosure also relates to diagnostic, prophylactic and therapeutic methods using anti-tau antibodies.
Crystal of azole benzene derivative
Teijin Pharma Limited
July 27, 2017 - N°20170210735

There are provided crystals of 2-[4-(2,2-dimethylpropoxy)-3-(1h-1,2,3,4-tetrazol-1-yl)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid which is useful as a therapeutic agent or prophylactic agent for gout, hyperuricemia and the like.
Compounds and compositions for intracellular delivery of therapeutic agents
Modernatx, Inc.
July 27, 2017 - N°20170210698

The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and peg lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as rna are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, ...
Compounds and compositions for intracellular delivery of therapeutic agents
Modernatx, Inc.
July 27, 2017 - N°20170210697

The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and peg lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as rna are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, ...
Vaccine composition against streptococcus suis infection
Idt Biologika Gmbh
July 27, 2017 - N°20170209561

Described is a vaccine composition comprising an effective amount of at least one polypeptide selected from the group of idessuis, ridessuis, an analogue or a fragment thereof, or a polynucleotide encoding the same. This vaccine composition is used in the prophylactic, metaphylactic or therapeutic treatment of a streptococcus suis infections in pigs or humans.
Loading